Deyuan Fu

830 total citations
35 papers, 614 citations indexed

About

Deyuan Fu is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Deyuan Fu has authored 35 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 14 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Deyuan Fu's work include Breast Cancer Treatment Studies (10 papers), MicroRNA in disease regulation (7 papers) and Global Cancer Incidence and Screening (4 papers). Deyuan Fu is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), MicroRNA in disease regulation (7 papers) and Global Cancer Incidence and Screening (4 papers). Deyuan Fu collaborates with scholars based in China and United States. Deyuan Fu's co-authors include Chuanli Ren, Jinli Wei, Chongxu Han, Yulin Luo, Daxin Wang, Zhengquan Zhang, Hui Chen, Jing Li, Hui Chen and Jiaxin Zhang and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Deyuan Fu

34 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deyuan Fu China 14 359 326 168 101 48 35 614
Francine E. Carrick United States 9 308 0.9× 111 0.3× 134 0.8× 105 1.0× 50 1.0× 10 604
F. De Vita Italy 11 198 0.6× 220 0.7× 405 2.4× 196 1.9× 25 0.5× 37 691
Binhui Ren China 17 568 1.6× 394 1.2× 151 0.9× 130 1.3× 20 0.4× 33 848
Shingo Kagawa Japan 17 329 0.9× 192 0.6× 328 2.0× 138 1.4× 28 0.6× 40 714
Hening Ren United States 15 621 1.7× 227 0.7× 257 1.5× 113 1.1× 31 0.6× 21 976
Kara Penne United States 7 260 0.7× 154 0.5× 256 1.5× 203 2.0× 10 0.2× 11 691
Paul V. Newcomb United Kingdom 11 281 0.8× 198 0.6× 157 0.9× 64 0.6× 57 1.2× 13 597
Emile Youssef United States 13 495 1.4× 126 0.4× 188 1.1× 95 0.9× 68 1.4× 18 713
Jamie McIntosh United Kingdom 7 209 0.6× 151 0.5× 325 1.9× 303 3.0× 15 0.3× 12 599
Kazushige Furuya Japan 13 375 1.0× 146 0.4× 310 1.8× 77 0.8× 33 0.7× 35 631

Countries citing papers authored by Deyuan Fu

Since Specialization
Citations

This map shows the geographic impact of Deyuan Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deyuan Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deyuan Fu more than expected).

Fields of papers citing papers by Deyuan Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deyuan Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deyuan Fu. The network helps show where Deyuan Fu may publish in the future.

Co-authorship network of co-authors of Deyuan Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Deyuan Fu. A scholar is included among the top collaborators of Deyuan Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deyuan Fu. Deyuan Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Wenjing, Xiaofan Jiang, Ruijin Xie, et al.. (2023). Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation. PeerJ. 11. e15703–e15703. 1 indexed citations
3.
4.
5.
Xu, An, et al.. (2022). Cytotoxic indole alkaloids and polyketides produced by a marine-derived fungus Aspergillus flavipes DS720. Frontiers in Microbiology. 13. 959754–959754. 6 indexed citations
6.
Fu, Deyuan, et al.. (2022). Influence of advanced age on the prognosis of triple-negative breast cancer patients: A surveillance, epidemiology, and end results-based study. Journal of Cancer Research and Therapeutics. 19(Suppl 1). S323–S327. 4 indexed citations
7.
Liang, Wei, et al.. (2022). Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort. Annals of Surgical Oncology. 29(9). 5772–5781. 32 indexed citations
8.
9.
Fu, Deyuan, Jing Li, Jinli Wei, et al.. (2018). HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer. Cell Communication and Signaling. 16(1). 8–8. 74 indexed citations
10.
Wei, Jinli, Jiaxin Zhang, & Deyuan Fu. (2018). Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study. World Journal of Surgical Oncology. 16(1). 236–236. 10 indexed citations
11.
Fu, Deyuan, et al.. (2018). PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α–Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer. Cellular Physiology and Biochemistry. 51(5). 2434–2444. 63 indexed citations
12.
Zhang, Jiaxin, et al.. (2018). Laminin is over expressed in breast cancer and facilitate cancer cell metastasis. Journal of Cancer Research and Therapeutics. 14(12). 1170–1170. 22 indexed citations
13.
Yang, Xueli, Zhengquan Zhang, Xiaoqing Jia, et al.. (2017). High expression of PLA2G16 is associated with a better prognosis in HER2-positive breast cancer. Journal of Thoracic Disease. 9(4). 1002–1011. 7 indexed citations
14.
15.
Ren, Chuanli, Wenshu Wang, Chongxu Han, et al.. (2016). Expression and prognostic value of miR-92a in patients with gastric cancer. Tumor Biology. 37(7). 9483–9491. 25 indexed citations
16.
Fu, Deyuan, et al.. (2015). Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer. Tumor Biology. 36(10). 8025–8034. 26 indexed citations
17.
Chen, Hui, Chuanli Ren, Chongxu Han, et al.. (2015). Expression and Prognostic Value of miR-486-5p in Patients with Gastric Adenocarcinoma. PLoS ONE. 10(3). e0119384–e0119384. 43 indexed citations
18.
Ren, Chuanli, et al.. (2014). Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer. Tumor Biology. 35(11). 11467–11472. 44 indexed citations
19.
Wei, Jinli, Deyuan Fu, & Jiaxin Zhang. (2012). Sentinel lymph node biopsy in papillary thyroid cancer. 6(4). 240–242. 2 indexed citations
20.
Ren, Chuanli, Hui Chen, Chongxu Han, Daxin Wang, & Deyuan Fu. (2012). Increased plasma microRNA and CD133/CK18-positive cancer cells in the pleural fluid of a pancreatic cancer patient with liver and pleural metastases and correlation with chemoresistance. Oncology Letters. 4(4). 691–694. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francine E. Carrick Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Binhui Ren Breakdown of academic impact, for papers by Shingo Kagawa Breakdown of academic impact, for papers by Hening Ren Breakdown of academic impact, for papers by Kara Penne Breakdown of academic impact, for papers by Paul V. Newcomb Breakdown of academic impact, for papers by Emile Youssef Breakdown of academic impact, for papers by Jamie McIntosh Breakdown of academic impact, for papers by Kazushige Furuya
Rankless by CCL
2026